CryoPort Balance Sheet | StatInvestor

Industrial Goods » Containers & Packaging | CryoPort Inc.

CryoPort Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Cash & Short Term Investments

563.10

369.60

1,405.20

4,524.50

15,042.20

47,258.10

Total Accounts Receivable

217.10

515.80

589.70

1,195.50

1,625.50

3,543.70

Inventories

39.20

29.70

69.70

89.50

114.80

220.50

Other Current Assets

22.40

98.10

97.30

286.90

516.40

752.30

Total Current Assets

841.80

1,013.20

2,161.90

6,096.40

17,298.90

51,774.50

Net Property, Plant & Equipment

505.50

408.90

307.90

1,647.10

2,511.20

4,357.50

Intangible Assets

272.30

180.10

136.80

5.00

90.60

137.20

Other Assets

136.30

107.80

363.40

350.80

Total Assets

1,755.80

1,710.00

2,606.60

8,111.90

20,264.10

56,620.10

ST Debt & Current Portion LT Debt

1,400.40

2,980.50

1,507.50

640.50

Accounts Payable

858.70

579.70

758.70

1,160.30

1,259.60

Other Current Liabilities

238.30

454.30

730.30

430.40

925.50

Total Current Liabilities

2,497.40

4,014.40

2,996.50

2,231.30

2,185.10

Long-Term Debt

1,321.70

26.50

Other Liabilities

200.30

192.20

Total Liabilities

3,819.10

4,014.40

3,022.90

2,431.50

2,377.30

Common Equity (Total)

2,063.30

2,304.50

416.90

5,680.40

17,886.80

Total Shareholders' Equity

2,063.30

2,304.50

416.30

5,680.40

17,886.80

Total Equity

2,063.30

2,304.50

416.30

5,680.40

17,886.80

Liabilities & Shareholders' Equity

1,755.80

1,710.00

2,606.60

8,111.90

20,264.10

Preferred Stock (Carrying Value)

0.60

About CryoPort

View Profile

Address	17305 Daimler Street Irvine California 92614 United States
Employees	-
Website	http://www.cryoport.com
Updated	07/08/2019
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures.